By Will Feuer Rain Oncology’s board of directors will review an unsolicited takeover attempt from Concentra Biosciences, an offer made through Tang Capital,…
Markets – MarketWatch
Rain Oncology to Review Takeover Offer of $1.25/Share Markets – MarketWatch
